( in Million)
Particulars
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1539.8
1454.6
164.3
37.1
Total Expenditure
103.6
110.4
90.4
91.5
PBIDT (Excl OI)
1436.2
1344.2
73.9
-54.4
Operating Profit
1439.8
1351.3
75.7
-53.5
Exceptional Items
NA
NA
NA
NA
Depreciation
9.6
10.1
9.2
2.7
Profit Before Tax
1429.4
1340.2
65.9
-56.8
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1236.7
1124
85
-66.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1236.7
1124
85
-66.4
Minority Interest
NA
NA
NA
NA
Shares of Associates
244.9
339
292.2
262.5
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1481.6
1463
377.2
196.1
Equity Capital
506
506
506
506
Face Value (IN RS)
1
10
10
10
Calculated EPS
2.92
28.91
7.45
3.87
Calculated EPS (Annualised)
11.71
115.65
29.81
15.50
No of Public Share Holdings
13466349
13466349
13466349
13466349
% of Public Share Holdings
26.62
26.62
26.62
26.62
PBIDTM% (Excl OI)
93.27
92.41
44.97
-146.63
PBIDTM%
93.50
92.89
46.07
-144.20
PBDTM%
93.45
92.82
45.70
-145.82
PBTM%
92.83
92.13
40.10
-153.09
PATM%
80.31
77.27
51.73
-178.97